BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chidambaram H, Chinnathambi S. G-Protein Coupled Receptors and Tau-different Roles in Alzheimer’s Disease. Neuroscience 2020;438:198-214. [DOI: 10.1016/j.neuroscience.2020.04.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Chidambaram H, Das R, Chinnathambi S. G-Protein coupled Purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin cytoskeleton remodelling in microglia. European Journal of Cell Biology 2022. [DOI: 10.1016/j.ejcb.2022.151201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Feng J, Song G, Shen Q, Chen X, Wang Q, Guo S, Zhang M. Protect Effects of Seafood-Derived Plasmalogens Against Amyloid-Beta (1-42) Induced Toxicity via Modulating the Transcripts Related to Endocytosis, Autophagy, Apoptosis, Neurotransmitter Release and Synaptic Transmission in SH-SY5Y Cells. Front Aging Neurosci 2021;13:773713. [PMID: 34899276 DOI: 10.3389/fnagi.2021.773713] [Reference Citation Analysis]
3 Dubey T, Chinnathambi S. Photodynamic treatment modulates various GTPase and cellular signalling pathways in Tauopathy. Small GTPases 2021;:1-13. [PMID: 34138681 DOI: 10.1080/21541248.2021.1940722] [Reference Citation Analysis]
4 Desale SE, Chidambaram H, Chinnathambi S. G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer's disease. Mol Biomed 2021;2:17. [PMID: 35006431 DOI: 10.1186/s43556-021-00036-1] [Reference Citation Analysis]
5 Jeong HH, Chandrakantan A, Adler AC. Obstructive Sleep Apnea and Dementia-Common Gene Associations through Network-Based Identification of Common Driver Genes. Genes (Basel) 2021;12:542. [PMID: 33918603 DOI: 10.3390/genes12040542] [Reference Citation Analysis]
6 Yang A, Liu C, Wu J, Kou X, Shen R. A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease. Eur J Pharmacol 2021;897:173950. [PMID: 33607107 DOI: 10.1016/j.ejphar.2021.173950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Gu JL, Liu F. Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target. Curr Med Sci 2020;40:1009-21. [PMID: 33428128 DOI: 10.1007/s11596-020-2282-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Martínez-Cué C, Rueda N. Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome. Int J Mol Sci 2020;21:E6906. [PMID: 32962300 DOI: 10.3390/ijms21186906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chidambaram H, Das R, Chinnathambi S. Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation. Cell Biosci 2020;10:109. [PMID: 32944223 DOI: 10.1186/s13578-020-00474-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Das R, Chinnathambi S. Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer's Disease. Neuroscience 2020;448:325-36. [PMID: 32941933 DOI: 10.1016/j.neuroscience.2020.09.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]